463 related articles for article (PubMed ID: 35880388)
1. Regulatory effect of gut microbes on blood pressure.
Yan D; Sun Y; Zhou X; Si W; Liu J; Li M; Wu M
Animal Model Exp Med; 2022 Dec; 5(6):513-531. PubMed ID: 35880388
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiota and blood pressure in experimental models.
Jama HA; Kaye DM; Marques FZ
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis contributes to the development of hypertension.
Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
[TBL] [Abstract][Full Text] [Related]
4. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
5. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
Li J; Yang X; Zhou X; Cai J
Antioxid Redox Signal; 2021 Apr; 34(10):811-830. PubMed ID: 32316741
[No Abstract] [Full Text] [Related]
6. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
Kang Y; Cai Y
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):110-117. PubMed ID: 29102544
[TBL] [Abstract][Full Text] [Related]
8. Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Chan JYH; Lee CT; Tain YL
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810197
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients.
Huang F; Li S; Chen W; Han Y; Yao Y; Yang L; Li Q; Xiao Q; Wei J; Liu Z; Chen T; Deng X
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678227
[TBL] [Abstract][Full Text] [Related]
10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
12. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
13. Randomized Clinical Trial: Probiotics Alleviated Oral-Gut Microbiota Dysbiosis and Thyroid Hormone Withdrawal-Related Complications in Thyroid Cancer Patients Before Radioiodine Therapy Following Thyroidectomy.
Lin B; Zhao F; Liu Y; Wu X; Feng J; Jin X; Yan W; Guo X; Shi S; Li Z; Liu L; Chen H; Wang H; Wang S; Lu Y; Wei Y
Front Endocrinol (Lausanne); 2022; 13():834674. PubMed ID: 35350100
[TBL] [Abstract][Full Text] [Related]
14. Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet.
Kong C; Gao R; Yan X; Huang L; Qin H
Nutrition; 2019 Apr; 60():175-184. PubMed ID: 30611080
[TBL] [Abstract][Full Text] [Related]
15. Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System.
Robles-Vera I; Toral M; Duarte J
Am J Hypertens; 2020 Oct; 33(10):890-901. PubMed ID: 32614942
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in kidney disease and hypertension.
Antza C; Stabouli S; Kotsis V
Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
[TBL] [Abstract][Full Text] [Related]
18. Microbiota medicine: towards clinical revolution.
Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus.
Lakshmanan AP; Shatat IF; Zaidan S; Jacob S; Bangarusamy DK; Al-Abduljabbar S; Al-Khalaf F; Petroviski G; Terranegra A
Biomed Pharmacother; 2021 Aug; 140():111736. PubMed ID: 34034069
[TBL] [Abstract][Full Text] [Related]
20. Implications of Gut Microbiota in Complex Human Diseases.
Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
